BIO5 Latest News

  • The morning and afternoon workshops, all of which are designed to enhance life sciences education in Arizona schools, include opportunities to build a Galileoscope, make soda-bottle biospheres, perform DNA fingerprinting, and analyze the genetics of breast cancer. Several workshops will take teachers into the Biosphere 2 dome, where they will collect environmental data within the desert, savannah and rainforest ecosystems. Teachers also will take part in an expo that highlights University of Arizona resources for K-12 science teachers, tour the facility, hear a keynote address about the current status of global climate change research, and network with other K-12 educators from around the state. On Saturday evening, former Biospherian Jane Poynter will talk about her two-year experience living and working inside Biosphere 2.
  • Dr. Martinez, a professor of pediatrics at the UA, is one of the most highly regarded researchers in the world in the area of childhood lung diseases.
     

  • Plenary speakers include:
    Roger Newton, Ph.D., is co-discoverer of Lipitor, the most prescribed cholesterol-reducing drug in the world. He worked at Warner-Lambert/Parke-Davis (now Pfizer) before starting Esperion Therapeutics, where he serves as founder, president and CEO.

  • The Arizona Board of Regents gave approval for a University of Arizona (UA) researcher to take on part ownership of the new Tucson company Cancer Prevention Pharmaceuticals (CPP). CPP's work may one day help prevent colon cancer in those at high risk for the disease.
     
    UA Professor of Cell Biology and Anatomy Eugene Gerner will run CPP with his colleague Frank L. Meyskens, Jr., Professor of Medicine and Director of the Chao Family Comprehensive Cancer Center at the University of California in Irvine.

Syndicate content